Sensus Healthcare (NASDAQ:SRTS) Stock Price Passes Below 50-Day Moving Average – Here’s What Happened

Sensus Healthcare, Inc. (NASDAQ:SRTS)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $3.74 and traded as low as $2.66. Sensus Healthcare shares last traded at $2.70, with a volume of 53,292 shares changing hands.

Wall Street Analyst Weigh In

Several analysts have weighed in on SRTS shares. Alliance Global Partners started coverage on Sensus Healthcare in a research note on Friday, March 6th. They set a “buy” rating and a $7.50 target price on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Sensus Healthcare in a research note on Tuesday, April 21st. Citigroup reaffirmed a “buy” rating on shares of Sensus Healthcare in a research note on Friday, May 8th. Wall Street Zen downgraded Sensus Healthcare from a “sell” rating to a “strong sell” rating in a research note on Saturday, May 9th. Finally, Maxim Group cut their target price on Sensus Healthcare from $8.00 to $6.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $6.88.

Sensus Healthcare Stock Performance

The stock has a 50 day moving average price of $3.74 and a 200 day moving average price of $4.09. The company has a market cap of $44.44 million, a P/E ratio of -5.74 and a beta of 1.09.

Sensus Healthcare (NASDAQ:SRTS) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.04). Sensus Healthcare had a negative return on equity of 15.79% and a negative net margin of 34.50%.The firm had revenue of $3.39 million during the quarter, compared to the consensus estimate of $5.32 million.

Institutional Trading of Sensus Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Greenline Wealth Management LLC acquired a new stake in shares of Sensus Healthcare during the fourth quarter worth $513,000. Divisadero Street Capital Management LP raised its position in shares of Sensus Healthcare by 39.5% during the third quarter. Divisadero Street Capital Management LP now owns 452,897 shares of the company’s stock worth $1,422,000 after purchasing an additional 128,224 shares during the period. Rothschild Wealth LLC acquired a new stake in shares of Sensus Healthcare during the fourth quarter worth $500,000. North Star Investment Management Corp. acquired a new stake in shares of Sensus Healthcare during the first quarter worth $500,000. Finally, Pacific Ridge Capital Partners LLC raised its position in shares of Sensus Healthcare by 21.8% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 698,634 shares of the company’s stock worth $2,781,000 after purchasing an additional 125,245 shares during the period. Institutional investors own 25.30% of the company’s stock.

About Sensus Healthcare

Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.

The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.